HEART Score for Major Cardiac Events

HEART Score for Major Cardiac Events
History
EKG
Age
Risk Factors
Troponin
HEART Score:
Select all criteria
Predicts 6-week risk of major adverse cardiac events in patients with chest pain.

Why Use

Objectively risk-stratifies patients into low, moderate, and high-risk categories, helping guide management, leading to better resource utilization, shorter hospital and ED stays for low risk patients, and earlier interventions for moderate- and high-risk patients.

When to Use

Any ED patient with chest pain that the physician deems appropriate for an ACS workup.

Formula

Addition of the selected points: 0 points 1 point 2 points History 1 Slightly suspicious Moderately suspicious Highly suspicious EKG Normal Non-specific repolarization disturbance 2 Significant ST deviation 3 Age (years) <45 45–64 ≥65 Risk factors 4 No known risk factors 1–2 risk factors ≥3 risk factors or history of atherosclerotic disease Initial troponin 5 ≤normal limit 1–3× normal limit >3× normal limit e.g. Retrosternal pain, pressure, radiation to jaw/left shoulder/arms, duration 5–15 min, initiated by exercise/cold/emotion, perspiration, nausea/vomiting, reaction on nitrates within mins, patient recognizes symptoms. Low risk features of chest pain include: well localized, sharp, non-exertional, no diaphoresis, no nausea or vomiting, and reproducible with palpation. LBBB, typical changes suggesting LVH, repolarization disorders suggesting digoxin, unchanged known repolarization disorders. Significant ST-segment deviation without LBBB, LVH, or digoxin. HTN, hypercholesterolemia, DM, obesity (BMI >30 kg/m²), smoking (current, or smoking cessation ≤3 mo), positive family history (parent or sibling with CVD before age 65). Use local, regular sensitivity troponin assays and corresponding cutoffs.

Pearls / Pitfalls

Helps ED providers risk-stratify chest pain patients into low, moderate, and high-risk groups. HEART is an acronym of its components: History, EKG, Age, Risk factors, and troponin. Each of these is scored with 0, 1 or 2 points. Designed to risk stratify patients with undifferentiated chest pain, not those already diagnosed with ACS. Identifies patients with higher risk of having a MACE (all-cause mortality, myocardial infarction, or coronary revascularization) in the following 6 weeks. The user needs some experience taking a detailed chest pain history and reading EKGs to adequately apply these two components of the score. Sometimes compared to TIMI Score for UA/NSTEMI and the GRACE ACS Risk Score (older ACS scores), but the latter two differ from the HEART in that they measure risk of death for patients with diagnosed ACS. The HEART Score outperforms the TIMI Score for UA/NSTEMI, safely identifying more low-risk patients. Most widely validated for regular sensitivity troponin, though has also been recently studied using high sensitivity troponin ( Ljung 2019 ).

Management

Scores 0-3 : 0.9-1.7% risk of adverse cardiac event. In the HEART Score study, these patients were discharged (0.99% in the retrospective study, 1.7% in the prospective study). Scores 4-6 : 12-16.6% risk of adverse cardiac event. In the HEART Score study, these patients were admitted to the hospital. (11.6% retrospective, 16.6% prospective). Scores ≥7 : 50-65% risk of adverse cardiac event. In the HEART Score study, these patients were candidates for early invasive measures. (65.2% retrospective, 50.1% prospective). A MACE (Major Adverse Cardiac Event) was defined as all-cause mortality, myocardial infarction, or coronary revascularization.

Critical Actions

Do not use if new ST-segment elevation requiring immediate intervention or clinically unstable patients.

More Information

Major Adverse Cardiac Event (MACE) was defined in this study as: AMI, PCI, CABG, death. Ryan Radecki of EM Literature of Note recommended emergency physicians use the HEART Score over the TIMI or GRACE scores for emergency department risk stratification of patients with possibly cardiac complaints.

Oh hi there 👋
It’s nice to meet you.

New scoring tools, dose references, and guideline summaries straight to your inbox.

We don’t spam! Read our privacy policy for more info.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *